Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 563707, 8 pages
http://dx.doi.org/10.1155/2014/563707
Research Article

Consensus on Control of Risky Nonvariceal Upper Gastrointestinal Bleeding in Taiwan with National Health Insurance

1Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
4Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
5Gastroenterology Endoscopy Center, Chang Gung Memorial Hospital, Linko, Taiwan
6Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
7Department of Internal Medicine, Tainan Hospital, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
8School of Medicine, Fu Jen Catholic University, No. 510 Zhongzheng Road, Xinzhuang District, New Taipei City 24205, Taiwan

Received 13 June 2014; Accepted 1 August 2014; Published 14 August 2014

Academic Editor: Seng-Kee Chuah

Copyright © 2014 Bor-Shyang Sheu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. N. Barkun, M. Bardou, E. J. Kuipers et al., “International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding,” Annals of Internal Medicine, vol. 152, no. 2, pp. 101–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Y. Sung, F. K. L. Chan, M. Chen et al., “Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding,” Gut, vol. 60, no. 9, pp. 1170–1177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Barkun, S. Sabbah, R. Enns et al., “The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting,” The American Journal of Gastroenterology, vol. 99, no. 7, pp. 1238–1246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Bensoussan, C. A. Fallone, A. N. Barkun et al., “A sampling of Canadian practices in managing nonvariceal upper gastrointestinal bleeding before recent guideline publication: is there room for improvement?” Canadian Journal of Gastroenterology, vol. 19, no. 8, pp. 487–495, 2005. View at Google Scholar · View at Scopus
  5. J. Y. W. Lau, A. Barkun, D. Fan, E. J. Kuipers, Y. Yang, and F. K. L. Chan, “Challenges in the management of acute peptic ulcer bleeding,” The Lancet, vol. 381, no. 9882, pp. 2033–2043, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. K. L. Chow and J. J. Y. Sung, “Non-NSAID non-H. pylori ulcer disease,” Best Practice and Research: Clinical Gastroenterology, vol. 23, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. OCEBM Levels of Evidence Working Group, The Oxford Levels of Evidence 1, Oxford Centre for Evidence-Based Medicine, 2014, http://www.cebm.net/index.aspx?o=1025.
  8. C. Villanueva, A. Colomo, A. Bosch et al., “Transfusion strategies for acute upper gastrointestinal bleeding,” The New England Journal of Medicine, vol. 368, no. 1, pp. 11–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Hedges, S. B. Dehoney, J. S. Hooper, J. Amanzadeh, and A. J. Busti, “Evidence-based treatment recommendations for uremic bleeding,” Nature Clinical Practice Nephrology, vol. 3, no. 3, pp. 138–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. C. Wu, S. S. Rathore, Y. Wang, M. J. Radford, and H. M. Krumholz, “Blood transfusion in elderly patients with acute myocardial infarction,” New England Journal of Medicine, vol. 345, no. 17, pp. 1230–1236, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Livio, E. Gotti, D. Marchesi, G. Mecca, G. Remuzzi, and G. de Gaetano, “Uraemic bleeding: role of anaemia and beneficial effect of red cell tranfusions,” The Lancet, vol. 2, no. 8306, pp. 1013–1015, 1982. View at Google Scholar · View at Scopus
  12. T. A. Rockall, R. F. A. Logan, H. B. Devlin, and T. C. Northfield, “Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage,” The Lancet, vol. 347, no. 9009, pp. 1138–1140, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Blatchford, W. R. Murray, and M. Blatchford, “A risk score to predict need for treatment for upper-gastrointestinal haemorrhage,” The Lancet, vol. 356, no. 9238, pp. 1318–1321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Wang, Y. W. Chen, Y. R. Young, C. J. Yang, and I. C. Chen, “A prospective comparison of 3 scoring systems in upper gastrointestinal bleeding,” The American Journal of Emergency Medicine, vol. 31, no. 5, pp. 775–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. O. Lo and J. Y. Lau, “Gastrointestinal bleeding,” Endoscopy, vol. 46, pp. 310–313, 2014. View at Google Scholar
  16. J. Y. Lau, W. K. Leung, J. C. Y. Wu et al., “Omeprazole before endoscopy in patients with gastrointestinal bleeding,” The New England Journal of Medicine, vol. 356, no. 16, pp. 1631–1640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Sreedharan, J. Martin, G. I. Leontiadis et al., “Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding (review),” Cochrane Database of Systematic Reviews, vol. 7, Article ID CD005415, 2010. View at Publisher · View at Google Scholar
  18. H. J. Lin, K. Wang, C. L. Perng et al., “Early or delayed endoscopy for patients with peptic ulcer bleeding: a prospective randomized study,” Journal of Clinical Gastroenterology, vol. 22, no. 4, pp. 267–271, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Tai, S. P. Huang, H. P. Wang et al., “High-risk ED patients with nonvariceal upper gastrointestinal hemorrhage undergoing emergency or urgent endoscopy: a retrospective analysis,” The American Journal of Emergency Medicine, vol. 25, no. 3, pp. 273–278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. H. Forrest, N. D. C. Finlayson, and D. J. C. Shearman, “Endoscopy in gastrointestinal bleeding,” The Lancet, vol. 2, no. 7877, pp. 394–397, 1974. View at Google Scholar · View at Scopus
  21. L. Laine and W. L. Peterson, “Bleeding peptic ulcer,” The New England Journal of Medicine, vol. 331, no. 11, pp. 717–727, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Calvet, M. Vergara, E. Brullet, J. P. Gisbert, and R. Campo, “Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers,” Gastroenterology, vol. 126, no. 2, pp. 441–450, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Marmo, G. Rotondano, R. Piscopo, M. A. Bianco, R. D'Angella, and L. Cipolletta, “Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials,” The American Journal of Gastroenterology, vol. 102, no. 2, pp. 279–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Laine and K. R. McQuaid, “Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials,” Clinical Gastroenterology and Hepatology, vol. 7, no. 1, pp. 33–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. N. Barkun, M. Martel, Y. Toubouti, E. Rahme, and M. Bardou, “Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses,” Gastrointestinal Endoscopy, vol. 69, no. 4, pp. 786–799, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-C. Yang, J.-S. Shin, X.-Z. Lin, P.-I. Hsu, K.-W. Chen, and C.-Y. Lin, “The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease,” Gastrointestinal Endoscopy, vol. 40, no. 5, pp. 562–566, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Hsu, X. Lin, S. Chan et al., “Bleeding peptic ulcer—risk factors for rebleeding and sequential changes in endoscopic findings,” Gut, vol. 35, no. 6, pp. 746–749, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. P. I. Hsu, K. H. Lai, X. Z. Lin et al., “When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding,” Gastrointestinal Endoscopy, vol. 44, no. 4, pp. 382–387, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. C. J. Kahi, D. M. Jensen, J. J. Y. Sung et al., “Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis,” Gastroenterology, vol. 129, no. 3, pp. 855–862, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. C. C. Lo, P. I. Hsu, G. H. Lo et al., “Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers,” Gastrointestinal Endoscopy, vol. 63, no. 6, pp. 767–773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Lin, W. Lo, F. Lee, C. Perng, and G. Tseng, “A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy,” Archives of Internal Medicine, vol. 158, no. 1, pp. 54–58, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. J. J. Sung, A. Barkun, E. J. Kuipers et al., “Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding,” Annals of Internal Medicine, vol. 150, no. 7, pp. 455–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Wang, M. H. Ma, H. Chou et al., “High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials,” Archives of Internal Medicine, vol. 170, no. 9, pp. 751–758, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-C. Chen, J.-Y. Lee, Y.-J. Fang et al., “Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 8, pp. 894–903, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Neumann, L. M. Letelier, G. Rada et al., “Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding,” Cochrane Database of Systematic Reviews, vol. 6, Article ID CD007999, 2013. View at Publisher · View at Google Scholar
  36. H. Yen, C. Yang, W. Su, M. Soon, S. Wu, and H. Lin, “Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy,” BMC Gastroenterology, vol. 12, article 66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. Sung, B. Y. Suen, J. C. Wu, J. Y. Lau, J. Y. Ching, and V. W. Lee, “Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy,” The American Journal of Gastroenterology, vol. 109, no. 7, pp. 1005–1010, 2014. View at Publisher · View at Google Scholar
  38. F. K. L. Chan, L. C. T. Hung, B. Y. Suen et al., “Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial,” Gastroenterology, vol. 127, no. 4, pp. 1038–1043, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. F. K. L. Chan, V. W. S. Wong, B. Y. Suen et al., “Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial,” The Lancet, vol. 369, no. 9573, pp. 1621–1626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. N. J. Liu, C. S. Lee, J. H. Tang et al., “Outcomes of bleeding peptic ulcers: a prospective study,” Journal of Gastroenterology and Hepatology, vol. 23, no. 8, pp. e340–e347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Zaragoza, J. M. Tenías, M. J. Llorente, and A. Alborch, “Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model,” Journal of Clinical Gastroenterology, vol. 42, no. 7, pp. 786–790, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. G.-Y. Tseng, C.-T. Fang, H.-J. Lin et al., “Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study,” Alimentary Pharmacology and Therapeutics, vol. 30, no. 4, pp. 406–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-C. Lin, K.-L. Wu, K.-W. Chiu et al., “Risk factors influencing the outcome of peptic ulcer bleeding in end stage renal diseases after initial endoscopic haemostasis,” International Journal of Clinical Practice, vol. 66, no. 8, pp. 774–781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Chen, H. Lin, S. Hwang, F. Lee, M. Hou, and S. Lee, “Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension,” Journal of Gastroenterology and Hepatology, vol. 11, no. 1, pp. 59–64, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. H. C. Cheng, A. W. Kao, C. H. Chuang, and B. S. Sheu, “The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses,” Digestive Diseases and Sciences, vol. 50, no. 7, pp. 1194–1201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Cheng, S. Chuang, Y. Kao, A. Kao, C. Chuang, and B. Sheu, “Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion,” Hepato-Gastroenterology, vol. 50, no. 54, pp. 2270–2273, 2003. View at Google Scholar · View at Scopus
  47. H. C. Cheng, W. L. Chang, Y. C. Yeh, W. Y. Chen, Y. C. Tsai, and B. S. Sheu, “Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities,” Gastrointestinal Endoscopy, vol. 70, no. 3, pp. 433–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. H. C. Cheng, C. T. Wu, W. L. Chang, W. C. Cheng, W. Y. Chen, and B. S. Sheu, “Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study,” Gut, 2014. View at Publisher · View at Google Scholar
  49. T. Komatsu, Y. Tamai, H. Takami, K. Yamagata, S. Fukuda, and A. Munakata, “Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures,” Journal of Gastroenterology, vol. 40, no. 7, pp. 698–707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. J. J. Y. Sung, J. Y. W. Lau, J. Y. L. Ching et al., “Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial,” Annals of Internal Medicine, vol. 152, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Hsu, “New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment,” Journal of Gastroenterology and Hepatology, vol. 27, no. 4, pp. 654–661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. C. P. Liu, W. C. Chen, K. H. Lai et al., “Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers,” American Journal of Gastroenterology, vol. 107, no. 7, pp. 1022–1029, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. K. C. Lai, K. M. Chu, W. M. Hui et al., “Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications,” Clinical Gastroenterology and Hepatology, vol. 4, no. 7, pp. 860–865, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. P. I. Hsu, K. H. Lai, and C. P. Liu, “Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis,” Gastroenterology, vol. 140, no. 3, pp. 791–798, 2011. View at Publisher · View at Google Scholar
  55. F. K. L. Chan, J. Y. L. Ching, and L. C. T. Hung, “Clopidogrel versus aspirin and esomeprazole to prevent recurrent ucler bleeding,” The New England Journal of Medicine, vol. 352, no. 3, pp. 317–319, 2005. View at Google Scholar · View at Scopus
  56. D. L. Bhatt, B. L. Cryer, C. F. Contant et al., “Clopidogrel with or without omeprazole in coronary artery disease,” The New England Journal of Medicine, vol. 363, no. 20, pp. 1909–1917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. K. F. Tsoi, H. C. H. Chan, P. W. Y. Chiu, C. Y. Y. Pau, J. Y. W. Lau, and J. J. Y. Sung, “Second-look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: a meta-analysis,” Journal of Gastroenterology and Hepatology, vol. 25, no. 1, pp. 8–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. E. Ouali, A. N. Barkun, J. Wyse et al., “Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis,” Gastrointestinal Endoscopy, vol. 76, no. 2, pp. 283–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. J.-C. Luo, H.-B. Leu, M.-C. Hou et al., “Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study,” Alimentary Pharmacology and Therapeutics, vol. 36, no. 6, pp. 542–550, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. C. C. Kuo, H. W. Kuo, I. M. Lee, C. T. Lee, and C. Y. Yang, “The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study,” BMC Nephrology, vol. 14, article 15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Luo, H. Leu, K. Huang et al., “Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis,” Canadian Medical Association Journal, vol. 183, no. 18, pp. E1345–E1351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. L. Peng, H. B. Leu, J. C. Luo et al., “Diabetes is an independent risk factor for peptic ulcer bleeding: a nationwide population-based cohort study,” Journal of Gastroenterology and Hepatology, vol. 28, no. 8, pp. 1295–1299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. K. W. Huang, J. C. Luo, H. B. Leu et al., “Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 7, pp. 796–802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Wu, M. Wu, K. N. Kuo, C. Wang, Y. Chen, and J. Lin, “Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study,” Gut, vol. 60, no. 8, pp. 1038–1042, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. C. Hsu, J. T. Lin, T. T. Chen, M. S. Wu, and C. Y. Wu, “Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study,” Hepatology, vol. 56, no. 2, pp. 698–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. C. H. Chang, H. C. Chen, J. W. Lin, C. W. Kuo, W. Y. Shau, and M. S. Lai, “Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan,” Pharmacoepidemiology and Drug Safety, vol. 20, no. 7, pp. 763–771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Lee, C. Chang, J. Lin, H. Chen, M. Lin, and M. Lai, “Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients,” Liver International, vol. 32, no. 5, pp. 859–866, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. N. Li, N. H. Wallén, M. Ladjevardi, and P. Hjemdahl, “Effects of serotonin on platelet activation in whole blood,” Blood Coagulation and Fibrinolysis, vol. 8, no. 8, pp. 517–523, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. C. Lee, W. Y. Shau, C. H. Chang, S. T. Chen, M. S. Lin, and M. S. Lai, “Antidepressant use and the risk of upper gastrointestinal bleeding in psychiatric patients: a nationwide cohort study in Taiwan,” Journal of Clinical Psychopharmacology, vol. 32, no. 4, pp. 518–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Wu, M. Wu, C. Wang, J. Cheng, K. N. Kuo, and J. Lin, “A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H. pylori eradication and proton pump inhibitor use,” Clinical Gastroenterology and Hepatology, vol. 7, no. 4, pp. 427–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Hsiao, Y. Tsai, Y. Wen, K. N. Kuo, C. Tsai, and W. Huang, “Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event,” Pharmacotherapy, vol. 31, no. 3, pp. 239–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. J. P. Gisbert, S. Khorrami, F. Carballo, X. Calvet, E. Gené, and J. E. Dominguez-Muñoz, “H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004062, 2004. View at Google Scholar · View at Scopus
  73. C. Wu, K. N. Kuo, M. Wu, Y. Chen, C. Wang, and J. Lin, “Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease,” Gastroenterology, vol. 137, no. 5, pp. 1641–1648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. B. C. Wong, S. K. Lam, W. M. Wong et al., “Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China, a randomized controlled trial,” The Journal of the American Medical Association, vol. 291, no. 2, pp. 187–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Fuccio, R. M. Zagari, L. H. Eusebi, L. Laterza, V. Cennamo, and L. Ceroni, “Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?” Annals of Internal Medicine, vol. 151, no. 2, pp. 121–128, 2009. View at Google Scholar · View at Scopus